BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19011446)

  • 1. Long-acting risperidone-induced periorbital edema.
    Pelizza L
    J Clin Psychopharmacol; 2008 Dec; 28(6):709-10. PubMed ID: 19011446
    [No Abstract]   [Full Text] [Related]  

  • 2. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral edema associated with risperidone oral solution: a case report and a review of the literature.
    Yang HN; Cheng YM
    J Clin Psychopharmacol; 2012 Feb; 32(1):128-30. PubMed ID: 22217945
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukopenia during therapy with risperidone long-acting injectable: two case reports.
    Uzun S; Kozumplik O; Jakovljević M; Folnegović-Smalc V
    J Clin Psychopharmacol; 2008 Dec; 28(6):713-4. PubMed ID: 19011449
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 6. Risperidone long-acting injection in practice - more questions than answers?
    Taylor D
    Acta Psychiatr Scand; 2006 Jul; 114(1):1-2. PubMed ID: 16774654
    [No Abstract]   [Full Text] [Related]  

  • 7. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 8. Risperidone-induced sialorrhea responsive to biperiden treatment.
    Panagiotidis PT; Fountoulakis KN; Siamouli M; Magiria S; Iacovides A; Kaprinis G
    Schizophr Res; 2007 Jul; 93(1-3):410-1. PubMed ID: 17462863
    [No Abstract]   [Full Text] [Related]  

  • 9. Follow-up of a pregnancy with risperidone microspheres.
    Dabbert D; Heinze M
    Pharmacopsychiatry; 2006 Nov; 39(6):235. PubMed ID: 17124649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.
    Bai YM; Chen TT; Lin WK; Chang WH; Wu B; Hung CH; Chou P; Chen JY
    J Clin Psychopharmacol; 2007 Jun; 27(3):306-8. PubMed ID: 17502783
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S
    Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
    Lai YC; Chiou CC; Chen CH; Huang MC
    J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
    [No Abstract]   [Full Text] [Related]  

  • 14. The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
    Peng PW; Huang MC; Tsai CJ; Pan CH; Chen CC; Chiu CC
    J Clin Psychopharmacol; 2008 Dec; 28(6):726-7; author reply 727-8. PubMed ID: 19011459
    [No Abstract]   [Full Text] [Related]  

  • 15. Angioedema - an unusual serious side effect of risperidone injection.
    Güneş F; Batgi H; Akbal A; Canatan T
    Clin Toxicol (Phila); 2013 Feb; 51(2):122-3. PubMed ID: 23336748
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between priapism and concurrent use of risperidone and Ginkgo biloba.
    Lin YY; Chu SJ; Tsai SH
    Mayo Clin Proc; 2007 Oct; 82(10):1289-90. PubMed ID: 17908535
    [No Abstract]   [Full Text] [Related]  

  • 17. Injection site pain with long-acting risperidone.
    Pinninti NR; Mago R
    J Clin Psychiatry; 2005 May; 66(5):656-7; author reply, 657. PubMed ID: 15889958
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved long-term outcome with long-acting risperidone treatment of chronic schizophrenia with prior partial response.
    Lindenmayer JP; Parak M; Gorman JM
    J Psychiatr Pract; 2006 Jan; 12(1):55-7. PubMed ID: 16432447
    [No Abstract]   [Full Text] [Related]  

  • 20. Inconsistency in risperidone long-acting injection steady-state plasma levels when switching from deltoid to gluteal administration.
    Elliott ES; Purvis TL; Nelson LA; Sommi RW
    J Clin Pharmacol; 2010 Jun; 50(6):721-4. PubMed ID: 20067943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.